Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents Rameda S.A.E. Announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was EGP 266.926 million compared to EGP 205.041 million a year ago. Operating income was EGP 52.467 million compared to EGP 31.957 million a year ago. Net income was EGP 31.603 million compared to EGP 19.870 million a year ago. Basic earnings per share from continuing operations was EGP 0.041 compared to EGP 0.026 a year ago. Diluted earnings per share from continuing operations was EGP 0.0411 compared to EGP 0.0259 a year ago. For the half year, sales was EGP 537.771 million compared to EGP 437.460 million a year ago. Operating income was EGP 101.486 million compared to EGP 78.406 million a year ago. Net income was EGP 61.765 million compared to EGP 43.765 million a year ago. Basic earnings per share from continuing operations was EGP 0.08 compared to EGP 0.057 a year ago. Diluted earnings per share from continuing operations was EGP 0.0804 compared to EGP 0.0569 a year ago.